$23.50
-1.31 (-5.28%)
EVI News30 articles
Palo Alto Networks Earnings Preview: Options Signal 8% Post-Report Volatility
Palo Alto Networks stock gained 2.5% Friday as traders positioned for earnings, with options markets implying an 8% swing. The cybersecurity firm reports Q2 results Tuesday after the Presidents Day holiday.
Stellantis Revives Diesel Models in Europe, Shares Dip Ahead of Earnings
Stellantis shares declined 1.9% to $7.75 after reports surfaced that the company is quietly bringing back diesel models in Europe, marking a strategic pivot as it prepares to report full-year results.
Analog Devices Nears 52-Week Peak on Barclays Upgrade Ahead of Earnings
Analog Devices shares climbed 1.73% to $337.10 on Friday, approaching a 52-week high, following an upgrade by Barclays. The firm anticipates quarterly results on February 18.
Analog Devices Gains on Barclays Upgrade Ahead of Earnings
Analog Devices shares advanced following an upgrade to Overweight by Barclays, which raised its price target to $375. The chipmaker reports quarterly results next week.
Amphenol Shares Dip in After-Hours Amid 10-K Review, CPI Anticipation
Amphenol shares declined slightly in extended trading following a volatile session, as the market digested the company's annual report and looked ahead to Friday's consumer price index release.
Analog Devices Dips After Barclays Upgrade, Eyes Earnings and CPI
Analog Devices shares declined 1.7% to $331.38, pulling back from a recent peak. The drop occurred even as Barclays upgraded the stock, citing potential industrial recovery.
NovoCure Shares Surge on FDA Approval for Pancreatic Cancer Device
NovoCure's stock jumped over 20% premarket after the FDA cleared its Optune Pax device for treating locally advanced pancreatic cancer, marking the first new treatment for this condition in nearly three decades.
BDX Surges 5% After Revising Long-Term Profit Outlook
Becton Dickinson shares rallied sharply in extended trading after the company updated its 2026 earnings forecast. Investors weighed margin pressures against a solid quarterly performance.
Lockheed Martin Shares Hold Steady Amid Pentagon Contractor Review
Lockheed Martin shares traded near $630 as the Pentagon initiates an extended review of major defense contractors, potentially impacting shareholder returns. CEO and CFO are scheduled to speak at a Citi conference next week.
Quince Therapeutics Surges on Strategic Review Announcement
Quince Therapeutics shares soared nearly 50% in premarket trading after the company hired LifeSci Capital to explore strategic alternatives and restructure liabilities, following a failed Phase 3 trial.
GSK's RSV Vaccine Advances in Chinese Regulatory Review, Eyes 2027 Decision
GSK's Arexvy RSV vaccine application has been accepted for review by China's drug regulator, with a potential approval decision expected in 2027. The stock edged higher as JPMorgan raised its price target and the company's dividend ex-date approaches.
FMC Shares Surge 7% Amid Strategic Review and Analyst Downgrades
FMC Corporation's stock climbed nearly 7% to $16.46 as investors assessed a new strategic review and a price target cut from Citigroup. Moody's also downgraded the company's debt to junk status.
Quince Therapeutics Engages LifeSci for Strategic Review Amid Phase 3 Setback
Quince Therapeutics shares fell 6.6% in premarket trading after hiring LifeSci Capital to explore strategic alternatives and debt restructuring, following a failed Phase 3 trial and board resignations.
GSK's RSV Vaccine Advances in China Review, Analysts Adjust Targets
GSK's respiratory syncytial virus vaccine Arexvy has entered regulatory review in China, a key market for adult immunization. The stock declined Monday despite several brokerages raising price targets.
OCBC Shares Dip Ahead of Earnings as Singapore Revises Growth Outlook
OCBC shares edged lower as Singapore raised its 2026 GDP forecast. Investors await the bank's Feb. 25 results following DBS's margin pressure warning.
Linde Shares Gain as Analysts Revise Targets Amid Strong Backlog Outlook
Linde shares rose 1.8% to $456.34 after analysts adjusted price targets, while the company projects robust 2026 earnings and maintains a record $10 billion project backlog.
Netflix Shares Dip After-Hours as Warner's UK Streaming Move Revives Deal Focus
Netflix stock declined 0.9% in extended trading following Warner Bros Discovery's announcement of HBO Max's UK launch and corporate restructuring plans that could shift entertainment assets to Netflix.
BD Revises 2026 Outlook Following Waters Spin-Off, Shares Dip
Becton Dickinson shares declined after the company lowered its 2026 profit forecast following the completion of its Biosciences unit spin-off to Waters Corporation.
Analog Devices Gains as UBS Lifts Target to $400 Ahead of Key Earnings
Analog Devices (ADI) shares advanced after UBS raised its price target to $400, citing strong data center and aerospace demand. Investor focus now shifts to the company's fiscal Q1 report due February 18.
Nexstar Shares Surge on Political Support for Tegna Acquisition Amid FCC Rule Review
Nexstar Media Group stock jumped 14.3% after former President Trump and FCC Chairman Carr endorsed its Tegna takeover. A Senate hearing on broadcast ownership rules is set for February 10.
Abbott Shares Gain on Insider Purchase and Positive Cardiac Device Data
Abbott Laboratories stock rose 1.6% Friday following a director's $1.09 million share purchase and new clinical data for its heart rhythm devices presented at a medical symposium.
Boeing Shares Gain Amid Dow Milestone, Pentagon Review Looms
Boeing stock rose 2.6% as the Dow closed above 50,000 for the first time. Investors await a Pentagon list of underperforming defense contractors that could restrict shareholder payouts.
Home Depot Earnings Preview: Inflation, Jobs Data Set Stage for Housing Demand Signals
Home Depot shares underperformed the broader market rally Friday as investors await key inflation and employment reports ahead of the retailer's quarterly results later this month.
Johnson & Johnson Stock Nears 52-Week High Amid Legal and Medical Device Updates
Johnson & Johnson shares approached a 52-week high as a New Jersey court disqualified a plaintiffs' firm from talc cases and the company reported positive pilot data for its atrial fibrillation platform.
JNJ Nears 52-Week Peak Amid Legal Win and Promising Heart Device Data
Johnson & Johnson shares approach a 52-week high after a New Jersey court disqualified a plaintiffs' firm from talc cases and the company released positive pilot data for its experimental atrial fibrillation platform.
MEXC Security Review Highlights Custody Safeguards Amid Industry Scrutiny
A recent security assessment of crypto exchange MEXC details its withdrawal controls and $100 million protection fund, while regulators question the adequacy of proof-of-reserves reports.
Applied Digital Soars 25% on AI Infrastructure Revival
Applied Digital shares surged 25.5% to $34.95 Friday amid heavy trading volume, driven by renewed investor interest in AI-linked infrastructure stocks. The company recently reported $126.6M in quarterly revenue and secured major data center leases.
Applied Digital Soars 25% on AI Infrastructure Revival, Eyes Key Economic Data
Applied Digital shares surged 25.5% to $34.95 Friday amid heavy trading volume, fueled by renewed investor interest in AI infrastructure stocks. The company's recent hyperscale lease signings and upcoming economic indicators are in focus.
DBS Earnings Preview: Investors Eye Margins and Payouts Ahead of FY2025 Results
DBS Group is set to release its full-year 2025 earnings on Monday, with market focus on net interest margins and capital returns as rate tailwinds fade. The stock closed at S$59.30 on Friday.
MACOM Shares Hold Gains After Strong Earnings and Revised Data Center Outlook
MACOM stock rose 3.5% to $235.87 following Q1 results and an increased data center growth forecast. Fidelity disclosed a 10.7% stake, while a shareholder filed to potentially sell shares.